NASDAQIndustrialsTruckingSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PAMT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Operating income improves toward break-even | PAMT is improving its operating income, reducing losses from $-5.7M to $-271K in one quarter. | Broken | operating income remains below -$271,000 over next 4 quarters | Operating income: $-10.408M FY2026-Q2; GAAP. Published target: >= -$271,000 in next 4 quarters. Target period is not explicitly aligned with this observation. Aug 7, 2026-10,408,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a cyclical, loss-making business with elevated risk, not a proven durable compounder. The long-term thesis is on watch: revenue growth has returned, but recent performance remains weak and well below its industry cohort.
The valuation evidence is mixed: PAMT is described as cheap versus peers, while the model also shows a peer premium and low confidence. The expectations gap is negative, but no fragility gates fired; the evidence does not clearly show that the valuation reflects a durable improvement.
Near term, revenue growth is encouraging, with Q2 revenue up year over year after a Q1 decline. But the operating loss widened in Q2 despite management’s cost-control focus, and erratic earnings plus a weaker jobs trend add risk to the next results. Management says it plans to step up repurchases, but actual volumes are not yet reported.
Over the next few quarters, the thesis depends on whether revenue growth can translate into better operating income. Continued strength from sector bellwethers could support the sector backdrop, while weaker results or guidance could remove that support. A further weakening in employment could also weigh on this cyclical business.
For the 1-to-3-year view, improving revenue offers a constructive sign, but persistent losses and sector risks keep the thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Revenue stabilizes or grows slightly |
| A primary condition in PAMT Corp.'s published investment case. The stated target is >= $141.9M revenue in next 4 quarters. |
| Intact |
| revenue falls below $141.9M in next 4 quarters |
Revenue: $164.652M FY2026-Q2; GAAP. Published target: >= $141.9M revenue in next 4 quarters. Target period is not explicitly aligned with this observation. Aug 7, 2026164,652,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Active share repurchases in Q2 2026 | The company plans active share buybacks in Q2 2026. | Intact | No share repurchases implemented in Q2 2026 | Buyback announced May 2026 vs Q2 2026 target May 1, 2026 announcement confirms active share repurchase implementation during Q2 2026 under existing authorization. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.